Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012

Published:2016-05-12 Issue:14 Volume:122 Page:2234-2241
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Baker Brock R.¹²^ORCID,Basak Ramsankar¹,Mohiuddin Jahan J.¹²,Chen Ronald C.¹³⁴

Affiliation:

1. Department of Radiation Oncology; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

2. School of Medicine; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

3. Cecil G. Sheps Center for Health Services Research; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

4. Lineberger Comprehensive Cancer Center; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Prostate cancer, version 2.2014;Mohler;J Natl Compr Canc Netw.,2014

2. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer;Sheets;JAMA.,2012

3. Dosimetric and physical comparison of IMRT and CyberKnife plans in the treatment of localized prostate cancer;Ceylan;Rep Pract Oncol Radiother.,2010

4. Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity;Yu;J Clin Oncol.,2014

5. Hypofractionation in prostate cancer: radiobiological basis and clinical appliance;Mangoni;Biomed Res Int.,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions;Intelligent Pharmacy;2024-07

2. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions;Cancers;2023-03-30

3. Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality;JCO Oncology Practice;2023-02

4. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments;Clinical and Translational Radiation Oncology;2023-01

5. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia;Radiation Oncology;2022-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3